Nano Labs (NA): Microcap AI-Chip Play with Big Optionality — Time to Size Up a Risky Long

Hook & thesis

Nano Labs (NA) is a small, underfollowed fabless chip designer that has drifted to microcap territory despite product traction in AI hardware and a recent MOU to explore North American AI data centers. At a market cap of roughly $43.99 million and a current share price around $1.90, the company is priced like a busted penny stock — yet the balance-sheet and corporate moves suggest real upside if a couple of catalysts land.

My trade idea: buy a small, well-sized position at $1.90, place a hard stop at $1.60, and take profits at $4.50 with a primary time horizon of long term (180 trading days). This is a high-risk, high-reward position meant for speculative capital only.

What Nano Labs does and why it matters

Nano Labs is a Hangzhou-headquartered holding company focused on design and product solutions for fabless integrated circuits. Its product mix includes high-throughput computing chips, high-performance computing chips, smart network interface cards, vision computing chips, distributed computing and storage solutions, and distributed rendering. The firm is small (about 67 employees) and young (founded in 2019), but it is operating directly in sectors that feed the AI compute supply chain.

Why the market should care: the secular story of AI compute is not limited to a handful of hyperscalers; edge inference, vision processing, smart NICs and distributed rendering will require specialized silicon and system-level solutions. Nano Labs has revenue and profitability metrics implied by a sub-2 P/E (around 1.96) and a price-to-book near 0.40, suggesting the market currently attributes little franchise value to its IP and go-to-market potential. That disconnect creates optionality if the company can show durable revenue growth or lock partnerships for data-center deployments.

Snapshot — quick numbers

Why now? Three near-term fundamental drivers

• MOU to explore North American AI data centers - On 04/24/2026 Nano Labs signed a non-binding Memorandum of Understanding with a U.S. partner to evaluate AI data centers, Agent Cloud platforms and AI-native payment infrastructure. If taken beyond evaluation, this could be a bridge into larger commercial deployments and recurring revenue streams.
• Insider conviction - The CEO, Jian Ping Kong, added 480,000 Class A shares on 08/26/2025. Insider buying of this size in a microcap signals alignment and confidence that management believes equity is undervalued.
• Product and ecosystem moves - The company has pushed into Real World Asset (RWA) infrastructure on blockchain and launched products targeted at AI applications; this indicates a strategy of layering software/network effects atop silicon, which can materially raise gross margins and customer stickiness if executed.

Technicals and market structure that support a speculative entry

Technically, the stock has been depressed: current price sits below the 10/20/50-day SMAs and the 9/21/50-day EMAs (SMA 10: $2.14, SMA 20: $2.35, SMA 50: $2.39). RSI is modest at ~39, and MACD shows bearish momentum but a small negative divergence (MACD line -0.128 vs signal -0.065). Those indicators tell us the market is cautious, but they also mean a relatively shallow technical rebound could trigger short-covering since short interest has climbed: short interest rose to ~926,590 shares as of 05/29 with days to cover near 10 on that snapshot.

Average volume measures are mixed: a two-week average near 253,697 and a 30-day average near 181,870 suggest there is occasional liquidity, though intraday swings can be large — treat size carefully.

Valuation framing

At a market cap of roughly $44 million and a P/E of ~1.96, Nano Labs is priced as if earnings are the primary, and perhaps only, value driver. The low P/B (0.40) and low market price relative to historical 52-week high ($31.48) reflect both the market's skepticism about sustainability and the fact the company is a small, China-based microcap — a combination that compresses multiples. Compare this to larger, more liquid AI-chip peers (not listed here), which trade at far higher multiples due to scale, credibility and stronger customer lists. The key to re-rating is demonstrable revenue growth, recurring contracts (data-center services or supplier agreements), or an acquisition path that surfaces IP value. Given the company's size, even a single mid-sized commercial deal could drive a multi-bagger from current levels.

Catalysts to watch (2-5)

• Progress on the 90-day evaluation with the North American partner (MOU announced 04/24/2026) - conversion to a pilot or commercial agreement would be a material positive.
• Quarterly results showing sequential revenue growth or expanding gross margins - a repeatable revenue cadence would change the narrative.
• New product announcements with demonstrable customer pilots for AI inference or smart NIC deployments.
• Additional insider buying or strategic investments/partnerships from recognized industry players.

Trade plan (actionable)

Primary trade idea: Establish a speculative long at $1.90. This is intended as a long-term position with the following parameters:

• Entry: $1.90.
• Stop loss: $1.60 (tight enough to limit drawdown but wide enough for intraday noise).
• Target: $4.50 (this implies more than 2x from entry; target reflects a modest re-rating and modest commercial traction for a microcap).
• Primary horizon: long term (180 trading days) — I expect the company's MOU evaluation, product pilots and potential early revenue recognition to play out over multiple quarters.

Alternate shorter windows:

• Mid term (45 trading days): scale for a quick pop if the MOU converts to a pilot or if press releases show customer engagement; partial profit at $2.70 to de-risk.
• Short term (10 trading days): this is high-volatility; use only for traders experienced with microcaps and tight position sizing.

Position sizing & execution notes

Treat this as a small allocation of speculative capital. Given low float (~9M) and elevated short interest, size your position so that a full stop does not jeopardize your portfolio. Enter in tranches to average in; consider scaling out at the mid-term take-profit and letting a smaller core ride toward the $4.50 target.

Risks and counterarguments

• Execution risk - converting an MOU into a revenue-generating customer is non-trivial. Many MOUs never lead to commercial contracts, and Nano Labs' small team (67 employees) limits execution bandwidth.
• Microcap and liquidity risk - the stock has a small market cap ($44M) and a float under 10M shares. That amplifies price moves, widens spreads, and can make exiting large positions difficult.
• Geopolitical and regulatory risk - being a China-based chip company operating in AI/data-center contexts invites regulatory and trade scrutiny that could impede North American expansion or partnerships.
• Short-squeeze and volatility - short interest has been rising (926k on 05/29 in the record), which can lead to sharp intraday runs and steep reversals. That volatility can work for or against long holders depending on timing.
• Counterargument: The market's low multiples may be correct. A P/E near 2 and P/B of 0.4 suggests the market expects limited durable profitability or potential write-offs. Management's insider buying is a positive signal, but it does not guarantee that the company can commercialize products at scale or secure meaningful recurring revenue. If no visible progress surfaces from the MOU or product pilots, the stock could re-test its recent low territory near $1.58.

What would change my mind

I would become more constructive and increase position size if the company reports: (1) a signed pilot or commercial contract from the MOU partner; (2) sequential revenue growth with improving gross margins; and (3) additional strategic partners or institutional investors validating the business model. Conversely, I would reduce exposure if: (a) the MOU evaluation concludes with no follow-up, (b) quarterly revenues remain flat or decline, or (c) regulatory headwinds materially block North American activities.

Conclusion - clear stance

Nano Labs is a speculative long with asymmetric upside if management can turn partnership talk into commercial contracts and recurring revenue. The combination of insider buying, a path into North American AI infrastructure, and low current valuation sets up an interesting risk/reward for patient, small-sized long positions. However, the company is a microcap with high operational and geopolitical risk; only allocate speculative capital you can afford to lose.

Key near-term monitor list

• Any update to the MOU with concrete pilots or contracts.
• Quarterly results indicating revenue or margin improvement.
• Additional insider or strategic investor activity.
• Short interest and volume spikes that could indicate squeezes or liquidity stress.

Trade plan recap: Enter long at $1.90, stop $1.60, target $4.50, primary horizon long term (180 trading days). Position size small; manage stops strictly.